These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15894525)

  • 21. Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients.
    Odri GA; Dumoucel S; Picarda G; Battaglia S; Lamoureux F; Corradini N; Rousseau J; Tirode F; Laud K; Delattre O; Gouin F; Heymann D; Redini F
    Cancer Res; 2010 Oct; 70(19):7610-9. PubMed ID: 20841471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
    Okamoto S; Kawamura K; Li Q; Yamanaka M; Yang S; Fukamachi T; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
    J Thorac Oncol; 2012 May; 7(5):873-82. PubMed ID: 22481236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Use of Zoledronic Acid Augments Ursolic Acid-Induced Apoptosis in Human Osteosarcoma Cells through Enhanced Oxidative Stress and Autophagy.
    Wu CC; Huang YF; Hsieh CP; Chueh PJ; Chen YL
    Molecules; 2016 Nov; 21(12):. PubMed ID: 27916903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute.
    Välimäki VV; Moritz N; Yrjans JJ; Vuorio E; Aro HT
    Bone; 2006 Mar; 38(3):432-43. PubMed ID: 16338190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronic acid modulates human osteosarcoma cells proliferation via GSK-3β activation.
    Li S; Li JJ
    Neoplasma; 2019 Sep; 66(5):766-775. PubMed ID: 31288526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis.
    Luo KW; Yue GG; Ko CH; Gao S; Lee JK; Li G; Fung KP; Leung PC; Lau CB
    Oncol Rep; 2015 Jul; 34(1):477-87. PubMed ID: 25998578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
    Clyburn RD; Reid P; Evans CA; Lefley DV; Holen I
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):969-78. PubMed ID: 19730863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.
    Ory B; Baud'huin M; Verrecchia F; Royer BB; Quillard T; Amiaud J; Battaglia S; Heymann D; Redini F; Lamoureux F
    Clin Cancer Res; 2016 May; 22(10):2520-33. PubMed ID: 26712686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid.
    Akens MK; Wise-Milestone L; Won E; Schwock J; Yee AJ; Wilson BC; Whyne CM
    Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):426-33. PubMed ID: 25176573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleiotropic effects of bisphosphonates on osteosarcoma.
    Ohba T; Cates JM; Cole HA; Slosky DA; Haro H; Ichikawa J; Ando T; Schwartz HS; Schoenecker JG
    Bone; 2014 Jun; 63():110-20. PubMed ID: 24636958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model.
    Cardemil C; Omar OM; Norlindh B; Wexell CL; Thomsen P
    Biomaterials; 2013 Feb; 34(5):1546-61. PubMed ID: 23182921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.
    Sewing L; Steinberg F; Schmidt H; Göke R
    Apoptosis; 2008 Jun; 13(6):782-9. PubMed ID: 18437576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest.
    Liu SS; Wang XP; Li XB; Liang JY; Liu LL; Lu Y; Zhong XY; Chen YX
    Biomed Pharmacother; 2014 Oct; 68(8):1031-6. PubMed ID: 25312823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivo.
    Brounais B; Chipoy C; Mori K; Charrier C; Battaglia S; Pilet P; Richards CD; Heymann D; Rédini F; Blanchard F
    Clin Cancer Res; 2008 Sep; 14(17):5400-9. PubMed ID: 18765531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes.
    Ohnuki H; Izumi K; Terada M; Saito T; Kato H; Suzuki A; Kawano Y; Nozawa-Inoue K; Takagi R; Maeda T
    Arch Oral Biol; 2012 Jul; 57(7):906-17. PubMed ID: 22172403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Tamura T; Shomori K; Nakabayashi M; Fujii N; Ryoke K; Ito H
    Oncol Rep; 2011 Apr; 25(4):1139-43. PubMed ID: 21249320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.
    Hashimoto K; Masumori N; Tanaka T; Maeda T; Kobayashi K; Kitamura H; Hirata K; Tsukamoto T
    Prostate; 2013 Apr; 73(5):500-11. PubMed ID: 22996996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
    Açil Y; Möller B; Niehoff P; Rachko K; Gassling V; Wiltfang J; Simon MJ
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages as potential targets for zoledronic acid outside the skeleton-evidence from in vitro and in vivo models.
    Rogers TL; Wind N; Hughes R; Nutter F; Brown HK; Vasiliadou I; Ottewell PD; Holen I
    Cell Oncol (Dordr); 2013 Dec; 36(6):505-14. PubMed ID: 24177992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.